Triple

T442845
Position Surface form Disambiguated ID Type / Status
Subject Cannabis E10150 entity
Predicate primaryReceptorTarget P815 FINISHED
Object CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
E55578 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CB1 receptor | Statement: [Cannabis, primaryReceptorTarget, CB1 receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: CB1 receptor
Context triple: [Cannabis, primaryReceptorTarget, CB1 receptor]
  • A. CBG
    CBG is the National Rail station code for Cambridge railway station in Cambridge, England.
  • B. CBX
    CBX is a pedestrian skybridge and terminal facility that connects San Diego directly to Tijuana International Airport, allowing ticketed passengers to cross the U.S.–Mexico border quickly and conveniently.
  • C. Pinaroloxias
    Pinaroloxias is a monotypic bird genus of Darwin’s finches, best known for the warbler finch endemic to the Galápagos Islands.
  • D. Cannabis
    Cannabis is a genus of flowering plants best known for producing psychoactive and medicinal compounds such as THC and CBD, widely used for recreational, therapeutic, and industrial (hemp) purposes.
  • E. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: CB1 receptor
Triple: [Cannabis, primaryReceptorTarget, CB1 receptor]
Generated description
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: CB1 receptor
Target entity description: The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • A. CBG
    CBG is the National Rail station code for Cambridge railway station in Cambridge, England.
  • B. CBX
    CBX is a pedestrian skybridge and terminal facility that connects San Diego directly to Tijuana International Airport, allowing ticketed passengers to cross the U.S.–Mexico border quickly and conveniently.
  • C. Pinaroloxias
    Pinaroloxias is a monotypic bird genus of Darwin’s finches, best known for the warbler finch endemic to the Galápagos Islands.
  • D. Cannabis
    Cannabis is a genus of flowering plants best known for producing psychoactive and medicinal compounds such as THC and CBD, widely used for recreational, therapeutic, and industrial (hemp) purposes.
  • E. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: primaryReceptorTarget
Context triple: [Cannabis, primaryReceptorTarget, CB1 receptor]
  • A. primaryTarget chosen
    Indicates that an entity is the main or most important target of another entity’s action, focus, or effect.
  • B. primaryTargetType
    Indicates the main category or type of entity that is the principal focus or intended recipient of an action, effect, or operation.
  • C. primaryRegulator
    Indicates that one entity serves as the main controlling or governing authority over another entity or process.
  • D. primaryPigment
    Indicates that one pigment is the main or dominant colorant used or present in relation to another entity.
  • E. primaryServes
    Indicates that one entity’s main or principal function is to serve, support, or provide service to another entity.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e8465ef481909655c681b01e2986 completed Feb. 28, 2026, 1:06 p.m.
NER Named-entity recognition batch_69a2ef43e8f88190a5d368add11a38c0 completed Feb. 28, 2026, 1:36 p.m.
NED1 Entity disambiguation (via context triple) batch_69a43e73555481909fc972eed3337945 completed March 1, 2026, 1:26 p.m.
NEDg Description generation batch_69a43ef8ac148190a077d00090f5c9f0 completed March 1, 2026, 1:28 p.m.
NED2 Entity disambiguation (via description) batch_69a43f55507c8190b922f21d2b59e82d completed March 1, 2026, 1:29 p.m.
PD Predicate disambiguation batch_69a2edde2b9c8190bd20b582eb4c5065 completed Feb. 28, 2026, 1:30 p.m.
Created at: Feb. 28, 2026, 1:11 p.m.